Open AccessIntranasal submucosal application of Bevacizumab in hereditary hemorrhagic telangiectasia (HHT) the effect on endothelial cell proliferation and VEGF expression an in vitro study
Author(s) -
E. Schäfer,
Nicole Rotter,
Daniel Häußler,
Haneen Sadick
Publication year - 2020
Publication title -
laryngo-, rhino-, otologie
Language(s) - English
Resource type - Conference proceedings
eISSN - 1438-8685
pISSN - 0935-8943
DOI - 10.1055/s-0040-1711350
Subject(s) - telangiectasia , bevacizumab , medicine , vascular endothelial growth factor , vegf receptors , dysplasia , vascular endothelial growth factor a , in vitro , pathology , cancer research , chemotherapy , biology , biochemistry